AERI - Aerie Pharmaceuticals last day of trading expected Nov. 18 as part of Alcon merger
- Aerie Pharmaceuticals' ( NASDAQ: AERI ) likely last day of trading on the Nasdaq will be on Nov. 18 as part of its merger with Alcon ( ALC ).
- With the acquisition, Alcon ( ALC ) gains Rocklatan and Rhopressa, eye drops to reduce intraocular pressure, as well as a pipeline of several clinical and preclinical candidates.
- In August, Alcon ( ALC ) said it would acquire Aerie ( AERI ) for ~$770M.
For further details see:
Aerie Pharmaceuticals last day of trading expected Nov. 18 as part of Alcon merger